CG Life Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

Recognition reflects sustained growth, strategic expansion, and continued investment in the future of life science communications

CHICAGO & SAN DIEGO & NEW YORK--(BUSINESS WIRE)--CG Life, a specialized pharma agency built for the unique challenges of bringing therapies for rare, specialty, and hard-to-treat diseases to market, has been named to the 2026 Inc. 5000, an annual ranking of the fastest-growing private companies in America.

The national honor recognizes CG Life for its continued business growth and significant expansion of its role as a commercialization partner for biopharma companies. Last month, CG Life combined with AI-native pharma agency, The Considered+AI. The union brings together deep scientific and commercialization expertise, an AI-native operating model, and world-class talent to help clients bring breakthrough therapies to market with greater speed, precision, and impact.

“This recognition by Inc. alongside so many of the country’s most dynamic, high-growth companies is a testament to the talented people at CG Life who bring their best every day,” said David Ormesher, CEO of CG Life. “Our industry is changing quickly. Science and technology are moving faster, product launches are getting more complex, and our clients need tighter relationships with their agency partners. We’ve been very deliberate about where we invest and the kind of company we’re building, so this honor from Inc. is a validation that we’re on the right path.”

CG Life’s growth story has been written over the past two decades of helping biopharma and life sciences companies translate complex science into meaningful commercial outcomes. The agency has developed deep expertise across rare and hard-to-treat diseases, where small, highly informed communities, complex science, and the need for strong evidence require a different approach to commercialization.

The addition of The Considered+AI further advances that strategy. CG Life is a modern commercialization partner designed to help clients move faster from insight to action while connecting more effectively with patients, caregivers, healthcare professionals, and advocacy communities.

Published annually by Inc., the Inc. 5000 recognizes the nation‘s most successful independent businesses based on percentage revenue growth over a three-year period. Companies appearing on the list have demonstrated remarkable resilience, innovation, and sustained expansion despite changing economic conditions.

About CG Life

Founded in 2003, CG Life is a specialized pharma agency built for the unique challenges of bringing therapies for rare and hard-to-treat diseases to market, where traditional commercialization models often fall short. CG Life partners with biopharma companies to navigate the complexities of rare disease commercial launches by combining deep scientific expertise, strategy-led activation of physician and patient communities, and results-driven engagement to support what’s best for patients. The result is faster, more effective launches in markets where insight, creativity, and credibility determine success. Begin your journey at CGLife.com.